1 Min Read
March 14 (Reuters) - Roche Diagnostics Canada -
* Health Canada has approved cobas EGFR mutation test v2 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.